4. Topical CsA versus placebo in people undergoing high‐risk keratoplasty.
Outcome | Topical CsA | Placebo | RR (95% CI) |
Graft rejection (immune reactions) at 1 year | 7/39 (17.9%) | 7/39 (17.9%) | 1.00 (0.39 to 2.58) |
Data from Sinha 2010
CsA: cyclosporine A RR: risk ratio CI: confidence interval